SAM
XBIT icon

Smartleaf Asset Management’s XBiotech XBIT Stock Holding History

Smartleaf Asset Management’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-84
Closed -$605 – 3023
2024
Q3 		$605 Buy
+84
New +$552 ﹤0.01% 2763

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Smartleaf Asset Management's XBIT Position: Q4 2024 in Review

Smartleaf Asset Management sold out of XBiotech (XBIT) in Q4 2024, closing a stake of 84 shares — an estimated $605 sold.

Smartleaf Asset Management first reported a position in XBIT in Q3 2024 and held it in 1 quarter. The position peaked at $605 in Q3 2024. 53 funds tracked by Wall St. Rank hold XBIT as of Q4 2024.

  • Smartleaf Asset Management reported no remaining XBiotech position as of Q4 2024 after selling out during the quarter.
  • Smartleaf Asset Management sold 84 XBiotech shares in Q4 2024, an estimated $605.
  • Smartleaf Asset Management first reported a position in XBiotech in Q3 2024 and held it in 1 quarter.
  • Smartleaf Asset Management's XBiotech position peaked at $605 in Q3 2024.
  • 53 funds tracked by Wall St. Rank held XBiotech as of Q4 2024.

Based on Smartleaf Asset Management's 13F filing for Q4 2024, filed 5 Feb 2025.